Position in CRBU
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$465,712
-$8,831 QoQ
Shares Held
245,112
-17.9% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 137 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 91.80497078886387.ToString("F0")%
Shared 0.ToString("F0")%
None 8.195029211136132.ToString("F0")%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. CRBU ranks #290 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in CRBU
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $465,712 | 245,112 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $474,543 | 298,456 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $834,648 | 358,219 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $417,663 | 331,481 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $440,760 | 482,764 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,371,857 | 2,749,597 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,348,401 | 1,198,165 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,014,316 | 618,487 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $2,130,511 | 414,497 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $6,330,575 | 1,104,813 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $8,688,504 | 1,817,679 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $5,383,612 | 1,266,733 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,633,503 | 1,249,248 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,719,165 | 1,229,167 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,813,941 | 1,214,592 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,492,480 | 643,183 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,862,509 | 202,888 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,555,293 | 103,068 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,259,285 | 52,756 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||